Indexed in SCIE, Scopus, PubMed & PMC
pISSN 1226-4512 eISSN 2093-3827

Editorial board

home Editors Editorial board

Editor-in-Chief

Sun-Hee Woo
Chungnam National University, Korea

Sun-hee Woo has been Professor of Physiology in the College of Pharmacy at Chungnam National University in South Korea since 2003. Her research interests are atrial local Ca2+ signaling and regulations of contraction and rhythm in cardiac muscle. Dr. Woo graduated from SungKyunKwan University College of Pharmacy, received her PhD degree at POSTECH in 1999, and did her postdoctoral research at Georgetown University Medical Center. She has been continuously investigating the regulatory mechanisms for cardiac excitation-contraction coupling and mechano-transduction.

Advisory Editors

Dong-Kuk Ahn
Kyungpook National University, Korea
Tong Mook Kang
Sungkyunkwan University, Korea
Sang Jeong Kim
Seoul National University, Korea
Jihee Lee
Ewha Womans University, Korea

Associate Editors

Seung-Kuy Cha
Yonsei University Wonju College of Medicine, Korea

Seung-Kuy Cha (PhD) serves as Professor in the Departments of Physiology and Global Medical Science at Yonsei University Wonju College of Medicine, Korea. After obtaining his PhD from Yonsei University in 2005, he pursued postdoctoral training at UT Southwestern Medical Center in Dallas, Texas, USA. Since 2010, he has directed a laboratory at Yonsei University, focusing on the endocrine FGF-Klotho axis, organelle medicine, and Ca2+ signaling. In 2024, he began his role as director of the BK21 Four Project, supported by national grants.
Youn-Hee Choi
Ewha Womans University, Korea

Youn-Hee Choi obtained MD degree from Ewha Womans University College of Medicine, followed by PhD degree from Yonsei University College of Medicine. After completing doctoral studies, she pursued postdoctoral fellowships at the University of Alabama at Birmingham. Since 2008, she has served as a Professor in the Department of Physiology at Ewha Womans University College of Medicine. Throughout her academic career, she has demonstrated a deep commitment to advancing our understanding of pathophysiological mechanisms and potential treatments in chronic inflammation, aging, and cancer.
Jin Han
Inje University, Korea

Jin Han, MD, PhD
College of Medicine, Inje University
His research focuses on the pathophysiology of heart failure, with a focus on the cardiovascular bioenergetics and mitochondrial function regulation, metabolic pathways and therapeutic targets in heart failure.
Hyoung Kyu Kim
Inje University, Korea

Professor Hyoung Kyu Kim is a professor at the Cardiovascular and Metabolic Disease Center at Inje University. He specializes in research on the physiological pathogenesis of cardiometabolic diseases and therapeutic target discovery targeting mitochondrial energy metabolism. His core research skills include physiological studies of mitochondrial function and cardiac dysfunction and omics-based proteomics-function studies. Research on treatment strategies through he has published more than 110 papers in the field of mitochondrial and cardiovascular and metabolic diseases. He received the 2014 Korean Physiological Society Emerging Physiologist Award and the 2022 ‘Yudang’ Best Academic Physiologist Award.
Sung Joon Kim
Seoul National University, Korea

Dr. Sung Joon Kim graduated Seoul National University College of Medicine, conducted PhD research at the same university (1997), and research fellow at Freiburg University (Germany). His research interest includes cardiovascular physiology, especially pulmonary arterial hypertension with right heart disease, and the electrophysiology of novel ion channels in immune cells. He published more than 185 peer-reviewed papers including J Physiol, J Gen Physiol, J Biol Chem, J Immunol, Basic Res Cardiol, ATVB, Sci Adv etc.
Yong-Seok Lee
Seoul National University, Korea

Yong-Seok Lee received his PhD in neuroscience from Seoul National University in Korea, followed by post-doctoral training at UCLA where he investigated mechanisms underlying learning deficits in neurodevelopmental disorders. His current research focuses on molecular, cellular, and circuit mechanisms of learning, memory, and social behaviors in mice.
Sang-Min Park
Chungnam National University, Korea

Sang-Min Park, Ph.D. is an Assistant Professor at the College of Pharmacy, Chungnam National University (CNU). He obtained B.S., M.S., and Ph.D. degrees from Korea Advanced Institute of Science and Technology (KAIST). He worked at Korea Institute of Oriental Medicine (KIOM) as a Senior Researcher. He has started a research group, the Systems Physiology Lab, at CNU. His research interests lie in (1) Data-Driven Drug Discovery, (2) Single-cell Analysis for Cancer Drug Resistance, and (3) Drug Repositioning for Natural Products.

Editorial Board

Young Min Bae
Konkuk University, Korea
Jungmin Choi
Korea University, Korea
Ka Young Chung
Sungkyunkwan University, Korea
Sun Wook Hwang
Korea University, Korea
Seung-Soon Im
Keimyung University, Korea
Ruji Inoue
Fukuoka University, Japan
Young-Ho Jin
Kyung Hee University, Korea
Dawon Kang
Gyeongsang National University, Korea
Hyung-Sik Kim
Pusan National University, Korea
Jae Ho Kim
Pusan National University, Korea
Karl Kunzelmann
University of Regensburg, Germany
Junko Kurokawa
University of Shizuoka, Japan
Hyo Bum Kwak
Inha University, Korea
Chae Hun Leem
University of Ulsan, Korea
Satoshi Matsuoka
University of Fukui, Japan
Sun Seek Min
Eulji University, Korea
Shmuel Muallem
National Institutes of Health, USA
Joo Hyun Nam
Dongguk University, Korea
Motohiro Nishida
Kyushu University, Japan
Seog Bae Oh
Seoul National University, Korea
Jin Bong Park
Seoul National University, Korea
Kyu-Sang Park
Yonsei University Wonju College of Medicine, Korea
Won Sun Park
Kangwon National University, Korea
Duck-Joo Rhie
The Catholic University of Korea, Korea
Dong Min Shin
Yonsei University, Korea
Dae-Kyu Song
Keimyung University, Korea
Byung-Chang Suh
Daegu Gyeongbuk Institute of Science & Technology, Korea
Jae Myoung Suh
KAIST Graduate School of Medical Science and Engineering,Korea
Jae Boum Youm
Inje University, Korea
Yin Hua Zhang
Seoul National University, Korea

Editor-in-Chief

Hyun Kook
Chonnam National University, Korea
Department of Pharmacology, College of Medicine

Dr. Kook’s research interests primarily focus on the molecular and cellular mechanisms underlying cardiovascular diseases, with a particular emphasis on post-transcriptional modifications and the regulatory roles of non-coding RNAs. He has explored how various non-coding RNAs influence cell signaling pathways and cellular differentiation in cardiovascular and muscular tissues. His work has significant implications in understanding the epigenetic regulation of cardiovascular diseases through post-translational modifications of histone or non-histone proteins, offering potential therapeutic targets for preventing or reversing cardiac and vascular remodeling.

Advisory Editors

Chul Hoon Kim
Yonsei University, Korea
Min Goo Lee
Yonsei University, Korea
Chang-Seon Myung
Chungnam National University, Korea

Associate Editors

Soo Kyung Bae
The Catholic University of Korea, Korea
College of Pharmacy

1) Non-clinical/clinical pharmacokinetic evaluation of drug candidates including natural products
2) In vitro/in vivo drug interaction evaluation of drug candidates
3) Development of LC-MS/MS analytical methods for drugs and their metabolites using biological samples
4) Development of physiological based pharmacokinetic modeling and simulation technology
5) Non-clinical pharmacokinetic evaluation of peptide and protein drugs
Kyung-Ok Cho
The Catholic University of Korea, Korea
Department of Pharmacology, College of Medicine

As an Associate Editor, I am interested in unraveling the molecular mechanisms of intractable brain diseases and the discovery of pharmacological treatments. This endeavor aims to identify novel therapeutic targets and develop effective interventions for conditions that currently lack adequate treatment options.
Area of responsibility: neuropharmacology
Kyung-Sun Heo
Chungnam National University, Korea
Department of Pharmacy, College of Pharmacy

Therapeutic target and drug development for vascular cell dysfunction
Therapeutic target and drug development for metabolic syndrome
Discovery for post-transcriptional modification (PTM) target regulator in vascular diseases
Chul-Ho Jeong
Keimyung University, Korea
Department of Pharmaceutics, College of Pharmacy

The Cancer Molecular Pharmacology Lab conducts research on integrated anti-cancer treatment strategies using multi-omics approaches to identify and overcome drug resistance in human cancers. Specifically, we focus on drug development research at the molecular level to clarify the mechanisms of action and metabolic targets involved in acquiring resistance to targeted anticancer drugs.
Chang-Han Lee
Seoul National University, Korea
Department of Biomedical Sciences at Seoul National University College of Medicine

Prof. Lee's research area excels at the cutting edge of biomedical research, specializing in therapeutics, immunology and biotechnology. His research group is at the forefront of developing innovative therapies, including monoclonal antibodies, bispecific antibodies, and advanced cellular therapies such as CAR-T. His research explores the immune response in depth to unlock new protective mechanisms and improve human health. His research group is using state-of-the-art platforms to advance antibody discovery and development, underscoring our commitment to pioneering new frontiers in medicine.
Jinu Lee
Yonsei University, Korea
College of Pharmacy

The main research topic is high throughput screening (HTS) for drug discovery. Cell-based phenotypic screening techniques are mainly used. Targets of interest include various GPCRs, NMDARs, and gap junctions. Genome engineering using CRISPR/Cas9 as a tool for assay development is also a research topic.
Hyungshin Yim
Hanyang University, Korea
Department of Pharmacy, College of Pharmacy

The research interests have encompassed the effects and action mechanisms of medicines that target oncogenes and signaling pathways through post-translational modification in cancer. Polo-like kinase 1 has been focused on as one of the targets for developing anticancer drugs in intractable cancer including metastatic and chemoresistant lung cancer

Editorial Board

Jun-ichi Abe
University of Texas, USA
Naohiko Anzai
Dokkyo Medical University, Japan
Kyun-Seop Bae
University of Ulsan, Korea
Han-Jung Chae
Chonbuk National University, Korea
Hyoung Chul Choi
Yeungnam University, Korea
Wanjoo Chun
Kangwon National University, Korea
Amteshwar Singh Jaggi
Punjabi University Patiala, India
Choon-Gon Jang
Sungkyunkwan University, Korea
Hong-Gu Joo
Jeju National University, Korea
Hak-Jae Kim
Soonchunhyang University, Korea
Hakrim Kim
Dankook University, Korea
Ja-Eun Kim
Kyung Hee University, Korea
Jee In Kim
Keimyung University, Korea
Koanhoi Kim
Pusan National University, Korea
Mi-Kyoung Kwak
The Catholic University of Korea, Korea
Kathleen G. Morgan
Boston University, USA
Ki-Wan Oh
Chungbuk National University, Korea
Lawrence A. Olatunji
University of Ilorin, Nigeria
Chang-Shin Park
Inha University, Korea
Uy Dong Sohn
Chung-Ang University, Korea
Yoh Takuwa
Kanazawa University, Japan
Christoph Thiemeermann
Queen Mary University of London, UK
Enyue Yang
Yanbian University Hospital, China
Sang Kyu Ye
Seoul National University, Korea
Young-Ran Yoon
Kyungpook National University, Korea

Manuscript Editor

Hai Mi Koo
Medrang Inc, Korea

Current Issue

May, 2024
Vol.28 No.3

Current Issue
All Issues

Journal Impact Factor (2022) 2.0

Most Read

Close ✕